Patents by Inventor John T. Yarrington

John T. Yarrington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5198457
    Abstract: The use of 1-(thienylalkyl)imidazole-2-thione derivatives as antihyperthyroid agents are described herein. These compounds may be administered as a preparatory adjunct procedure when thyroidectomy or radioactive iodine therapy is the recommended therapy or as a primary therapy when surgical procedures is not recommended or long term therapy is advisabe.
    Type: Grant
    Filed: April 17, 1992
    Date of Patent: March 30, 1993
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: John T. Yarrington
  • Patent number: 4847276
    Abstract: This invention relates to a novel method for the treatment of hemorrhagic and thrombotic thrombocytosis by means of administration of a 5-(4-chlorophenyl)-2,4-dimethyl-3H-1,2,4-triazole-3-thione.
    Type: Grant
    Filed: September 6, 1988
    Date of Patent: July 11, 1989
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: John T. Yarrington